In SilicoModeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In SilicoModeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 23, Pages 14441-14453
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-04-07
DOI
10.1074/jbc.m114.628826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin
- (2014) S. Dalva-Aydemir et al. CLINICAL CANCER RESEARCH
- Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With Type 2 Diabetes Mellitus: A Randomized, Blinded, Prospective Phase III Study
- (2014) Linong Ji et al. CLINICAL THERAPEUTICS
- Safety Profile of Dapagliflozin for Type 2 Diabetes: Pooled Analysis of Clinical Studies for Overall Safety and Rare Events
- (2014) Agata Ptaszynska et al. DRUG SAFETY
- Efficacy and safety of canagliflozin in subjects with type 2 diabetes: systematic review and meta-analysis
- (2014) Xu-Ping Yang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Isoform-selective Inhibition of Facilitative Glucose Transporters
- (2014) Richard C. Hresko et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin
- (2014) Kehinde U. A. Adekola et al. LEUKEMIA & LYMPHOMA
- Crystal structure of the human glucose transporter GLUT1
- (2014) Dong Deng et al. NATURE
- Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy
- (2012) S. K. McBrayer et al. BLOOD
- Broad Coverage of Commercially Available Lead-like Screening Space with Fewer than 350,000 Compounds
- (2012) Jonathan B. Baell Journal of Chemical Information and Modeling
- ZINC: A Free Tool to Discover Chemistry for Biology
- (2012) John J. Irwin et al. Journal of Chemical Information and Modeling
- HIV Protease Inhibitors Act as Competitive Inhibitors of the Cytoplasmic Glucose Binding Site of GLUTs with Differing Affinities for GLUT1 and GLUT4
- (2011) Richard C. Hresko et al. PLoS One
- Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
- (2011) D. A. Chan et al. Science Translational Medicine
- Effects of the HIV Protease Inhibitor Ritonavir on GLUT4 Knock-out Mice
- (2010) Arpita Kalla Vyas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
- (2009) T. B. Bartel et al. BLOOD
- The Prognostic Value of F-18 Fluorodeoxyglucose Bone Marrow Uptake in Patients With Recent Diagnosis of Multiple Myeloma
- (2009) Massimo Castellani et al. CLINICAL NUCLEAR MEDICINE
- Kinetics of transport and phosphorylation of glucose in cancer cells
- (2009) Sara Rodríguez-Enríquez et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
- (2008) S. Han et al. DIABETES
- Plasma Cell Disorders: An Historical Perspective
- (2008) N. C. Munshi Hematology-American Society of Hematology Education Program
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now